Annual Operating Profit
-$61.14 M
-$15.90 M-35.15%
31 December 2023
Summary:
Acumen Pharmaceuticals annual operaing income is currently -$61.14 million, with the most recent change of -$15.90 million (-35.15%) on 31 December 2023. During the last 3 years, it has fallen by -$53.23 million (-672.72%). ABOS annual operating profit is now -683.32% below its all-time high of -$7.80 million, reached on 31 December 2019.ABOS Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Operating Profit
-$32.27 M
-$7.88 M-32.34%
30 September 2024
Summary:
Acumen Pharmaceuticals quarterly operating income is currently -$32.27 million, with the most recent change of -$7.88 million (-32.34%) on 30 September 2024. Over the past year, it has dropped by -$16.23 million (-101.17%). ABOS quarterly operating profit is now -2306.04% below its all-time high of -$1.34 million, reached on 01 December 2020.ABOS Quarterly Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM Operating Profit
-$92.91 M
-$16.23 M-21.16%
30 September 2024
Summary:
Acumen Pharmaceuticals TTM operating income is currently -$92.91 million, with the most recent change of -$16.23 million (-21.16%) on 30 September 2024. Over the past year, it has dropped by -$36.01 million (-63.28%). ABOS TTM operating profit is now -4440.86% below its all-time high of -$2.05 million, reached on 31 March 2020.ABOS TTM Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ABOS Operating Profit Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -35.1% | -101.2% | -63.3% |
| 3 y3 years | -672.7% | -720.0% | -642.6% |
| 5 y5 years | - | - | - |
ABOS Operating Profit High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -672.7% | at low | -720.0% | at low | -642.6% | at low |
| 5 y | 5 years | -683.3% | at low | -2306.0% | at low | -4440.9% | at low |
| alltime | all time | -683.3% | at low | -2306.0% | at low | -4440.9% | at low |
Acumen Pharmaceuticals Operating Profit History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$32.27 M(+32.3%) | -$92.91 M(+21.2%) |
| June 2024 | - | -$24.38 M(+37.2%) | -$76.68 M(+16.6%) |
| Mar 2024 | - | -$17.77 M(-3.9%) | -$65.78 M(+7.6%) |
| Dec 2023 | -$61.14 M(+35.2%) | -$18.49 M(+15.3%) | -$61.14 M(+7.4%) |
| Sept 2023 | - | -$16.04 M(+19.0%) | -$56.90 M(+8.9%) |
| June 2023 | - | -$13.48 M(+2.6%) | -$52.23 M(+6.2%) |
| Mar 2023 | - | -$13.13 M(-7.8%) | -$49.16 M(+8.7%) |
| Dec 2022 | -$45.24 M | -$14.25 M(+25.3%) | -$45.24 M(+14.8%) |
| Sept 2022 | - | -$11.37 M(+9.2%) | -$39.40 M(+23.3%) |
| June 2022 | - | -$10.41 M(+13.1%) | -$31.97 M(+27.9%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2022 | - | -$9.21 M(+9.4%) | -$25.00 M(+27.6%) |
| Dec 2021 | -$19.58 M(+147.5%) | -$8.41 M(+113.9%) | -$19.58 M(+56.5%) |
| Sept 2021 | - | -$3.94 M(+14.4%) | -$12.51 M(+13.1%) |
| June 2021 | - | -$3.44 M(-9.3%) | -$11.06 M(+14.6%) |
| Mar 2021 | - | -$3.79 M(+182.8%) | -$9.66 M(+22.1%) |
| Dec 2020 | -$7.91 M(+1.4%) | - | - |
| Dec 2020 | - | -$1.34 M(-46.1%) | -$7.91 M(+20.4%) |
| Sept 2020 | - | -$2.49 M(+22.4%) | -$6.57 M(+61.0%) |
| June 2020 | - | -$2.04 M(-0.5%) | -$4.08 M(+99.5%) |
| Mar 2020 | - | -$2.05 M | -$2.05 M |
| Dec 2019 | -$7.80 M | - | - |
FAQ
- What is Acumen Pharmaceuticals annual operaing income?
- What is the all time high annual operating profit for Acumen Pharmaceuticals?
- What is Acumen Pharmaceuticals annual operating profit year-on-year change?
- What is Acumen Pharmaceuticals quarterly operating income?
- What is the all time high quarterly operating profit for Acumen Pharmaceuticals?
- What is Acumen Pharmaceuticals quarterly operating profit year-on-year change?
- What is Acumen Pharmaceuticals TTM operating income?
- What is the all time high TTM operating profit for Acumen Pharmaceuticals?
- What is Acumen Pharmaceuticals TTM operating profit year-on-year change?
What is Acumen Pharmaceuticals annual operaing income?
The current annual operating profit of ABOS is -$61.14 M
What is the all time high annual operating profit for Acumen Pharmaceuticals?
Acumen Pharmaceuticals all-time high annual operaing income is -$7.80 M
What is Acumen Pharmaceuticals annual operating profit year-on-year change?
Over the past year, ABOS annual operaing income has changed by -$15.90 M (-35.15%)
What is Acumen Pharmaceuticals quarterly operating income?
The current quarterly operating profit of ABOS is -$32.27 M
What is the all time high quarterly operating profit for Acumen Pharmaceuticals?
Acumen Pharmaceuticals all-time high quarterly operating income is -$1.34 M
What is Acumen Pharmaceuticals quarterly operating profit year-on-year change?
Over the past year, ABOS quarterly operating income has changed by -$16.23 M (-101.17%)
What is Acumen Pharmaceuticals TTM operating income?
The current TTM operating profit of ABOS is -$92.91 M
What is the all time high TTM operating profit for Acumen Pharmaceuticals?
Acumen Pharmaceuticals all-time high TTM operating income is -$2.05 M
What is Acumen Pharmaceuticals TTM operating profit year-on-year change?
Over the past year, ABOS TTM operating income has changed by -$36.01 M (-63.28%)